Citigroup’s Firefly Neuroscience AIFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53K Sell
2,091
-26,572
-93% -$46.3K ﹤0.01% 5365
2026
Q1
$62.5K Buy
+28,663
New +$35.7K ﹤0.01% 4437
2025
Q4
Sell
-811
Closed -$2.36K 6571
2025
Q3
$2.36K Buy
811
+488
+151% +$1.38K ﹤0.01% 5445
2025
Q2
$914 Buy
+323
New +$1.02K ﹤0.01% 5408

Other funds holding AIFF

Citigroup's AIFF Position: Q2 2026 in Review

Citigroup reduced its Firefly Neuroscience (AIFF) stake by 93% in Q2 2026, selling an estimated $46.3K and leaving 2,091 shares worth $2.53K. The position accounts for ﹤0.01% of the portfolio, ranked #5365.

Citigroup first reported a position in AIFF in Q2 2025 and has held it in 4 quarters since. The position peaked at $62.5K in Q1 2026. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • Citigroup held 2,091 shares of Firefly Neuroscience worth $2.53K as of Q2 2026.
  • Citigroup sold 26,572 Firefly Neuroscience shares in Q2 2026, an estimated $46.3K.
  • Firefly Neuroscience made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5365 holding.
  • Citigroup first reported a position in Firefly Neuroscience in Q2 2025 and has held it in 4 quarters since.
  • Citigroup's Firefly Neuroscience position peaked at $62.5K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.